RecruitingInfluenzaCOVID-19
Patient-Centered Practical Vaccine Talk For Busy Clinicians
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this study is to assess the effect of an educational intervention for primary care providers (PCPs) on influenza and COVID-19 vaccine uptake among their adult patients through a pragmatic, cluster randomized trial in primary care clinics.
Sponsor: University of Massachusetts, Worcester
You may qualify if…
- ✓ Practicing primary care provider at study clinic during the study period
- ✓ Licensed independent practitioner (MD, DO, NP, PA), including residents
- ✓ Receipt of the 2026/2027 influenza vaccine, among eligible patients:
- ✓ Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 influenza vaccine season\*
- ✓ Have not received the 2026-2027 influenza vaccine prior to the qualifying clinic visit (patients who receive the influenza vaccine on the day of the qualifying study visit are eligible)
- ✓ Adult (age \>= 18 years)
- ✓ Receipt of the 2026/2027 COVID-19 vaccine, among eligible patients:
- ✓ Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 COVID-19 vaccine season\*
You may not qualify if…
- ✕ PCPs at participating clinic sites who are members of the investigational team or part of the intervention
- ✕ PCP participants who practice at more than one study clinic that are assigned to discordant study arms (e.g., control and intervention) will be excluded at the outset of the study.
- ✕ Resident of a state that does not share immunization data with the Massachusetts Immunization Information System (MIIS)
- ✕ For the purposes of this study, the 2026/2027 influenza and COVID-19 vaccine seasons are defined as September 1, 2026, or date the respective vaccine is available (whichever is later) through February 28, 2027. These dates were selected based on the timing of influenza and COVID-19 vaccine administration in prior years according to the Massachusetts immunization for respiratory disease data. This is referred to as the 'study period' elsewhere in the protocol.
Where it's recruiting
Massachusetts
Worcester
Source: ClinicalTrials.gov · NCT07651761 · last updated 2026-06-18